Literature DB >> 16888388

Molecular mediators of alphavbeta3-induced endothelial cell survival.

Julie Rice1, Donald L Courter, Cecilia M Giachelli, Marta Scatena.   

Abstract

The alphavbeta3 integrin interaction with the extracellular matrix (ECM) plays an essential role in inhibiting apoptosis in endothelial cells. We have recently shown that alphavbeta3 ligation on rat aortic endothelial cells (RAECs) specifically activates the transcription factor nuclear factor kappaB (NF-kappaB) and promotes cell survival. Inhibiting NF-kappaB nuclear translocation abolished the protective effect of alphavbeta3 ligands. Here, we report that ligation of alphavbeta3 by its ligand, osteopontin (OPN), induces the phosphorylation and activation of inhibitory kappa B kinase beta IKKbeta and promotes the specific degradation of inhibitory kappa Balpha (IkappaBalpha) in RAECs. Overexpression of a dominant negative (DN) IKKbeta protein prevents IkappaBalpha phosphorylation, NF-kappaB activation, and inhibits the protective effects of OPN. The NF-kappaB-inducing kinase (NIK) has been shown to be one of the upstream kinases involved in IKK activation. OPN-mediated NF-kappaB activity is increased upon NIK wild-type (WT) overexpression and blocked following NIK DN overexpression. In addition, NIK-/-mouse embryonic fibroblasts (MEFs) plated on OPN display reduced NF-kappaB activity and decreased IkappaBalpha phosphorylation compared to NIK+/+MEFs. Finally, functional inhibition of integrin beta3-dependent NF-kappaB signaling decreases OPN-induced IkappaBalpha, IKKbeta and NIK phosphorylation. These studies for the first time show that the alphavbeta3-NF-kappaB-dependent endothelial survival pathway is dependent on IkappaBalpha, IKKbeta, and NIK. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888388     DOI: 10.1159/000094884

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  11 in total

Review 1.  Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.

Authors:  Thomas E Kruger; Andrew H Miller; Andrew K Godwin; Jinxi Wang
Journal:  Crit Rev Oncol Hematol       Date:  2013-09-07       Impact factor: 6.312

2.  Antigen-specific induction of osteopontin contributes to the chronification of allergic contact dermatitis.

Authors:  Anne M Seier; Andreas C Renkl; Guido Schulz; Tanja Uebele; Anca Sindrilaru; Sebastian Iben; Lucy Liaw; Shigeyuki Kon; Toshimitsu Uede; Johannes M Weiss
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

3.  The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.

Authors:  Donald Courter; Hongbin Cao; Shirley Kwok; Christina Kong; Alice Banh; Peiwen Kuo; Donna M Bouley; Carmen Vice; Odd Terje Brustugun; Nicholas C Denko; Albert C Koong; Amato Giaccia; Quynh-Thu Le
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

Review 4.  Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.

Authors:  Akeila Bellahcène; Vincent Castronovo; Kalu U E Ogbureke; Larry W Fisher; Neal S Fedarko
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

5.  Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.

Authors:  Yasuto Yamaguchi; Zhifei Shao; Shadi Sharif; Xiao-Yan Du; Timothy Myles; Milton Merchant; Griffith Harsh; Michael Glantz; Lawrence Recht; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

Review 6.  Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.

Authors:  David A Reardon; L Burt Nabors; Roger Stupp; Tom Mikkelsen
Journal:  Expert Opin Investig Drugs       Date:  2008-08       Impact factor: 6.206

7.  Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.

Authors:  Andrea Callegari; Matthew L Coons; Jerry L Ricks; Michael E Rosenfeld; Marta Scatena
Journal:  J Vasc Res       Date:  2014-03-07       Impact factor: 1.934

8.  Plexin-B1 activates NF-κB and IL-8 to promote a pro-angiogenic response in endothelial cells.

Authors:  Ying-Hua Yang; Hua Zhou; Nada O Binmadi; Patrizia Proia; John R Basile
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

9.  Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells.

Authors:  Monica E Burgett; Justin D Lathia; Patrick Roth; Amy S Nowacki; Deni S Galileo; Elena Pugacheva; Ping Huang; Amit Vasanji; Meizhang Li; Tatiana Byzova; Tom Mikkelsen; Shideng Bao; Jeremy N Rich; Michael Weller; Candece L Gladson
Journal:  Oncotarget       Date:  2016-07-12

Review 10.  NF-kappa B: a new player in angiostatic therapy.

Authors:  Sebastien P Tabruyn; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2008-02-19       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.